We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+11.4%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.6B
AUM Growth
+$2.24B
(+5.5%)
Cap. Flow
-$670M
Cap. Flow
% of AUM
-1.57%
Top 10 Holdings %
Top 10 Hldgs %
15.36%
Holding
2,428
New
206
Increased
703
Reduced
1,198
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$204M |
| 2 |
JPMorgan Chase
JPM
|
+$72.8M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$67.5M |
| 4 |
Evergy
EVRG
|
+$66.6M |
| 5 |
NVIDIA
NVDA
|
+$58.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$370M |
| 2 |
United Parcel Service
UPS
|
+$364M |
| 3 |
Dominion Energy
D
|
+$172M |
| 4 |
Moderna
MRNA
|
+$125M |
| 5 |
Teladoc Health
TDOC
|
+$114M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.43% |
| 2 | Technology | 20.08% |
| 3 | Consumer Discretionary | 10.99% |
| 4 | Financials | 9.65% |
| 5 | Industrials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Align Technology
ALGN
$10.7B
| $10.9M | 0.03% |
33,154
+17,266
| +109% | +$5.27M |
|
552
Fate Therapeutics
FATE
$292M
| $10.8M | 0.03% |
271,258
-94,794
| -26% | -$3.31M |
|
553
Brighthouse Financial
BHF
$2.81B
| $10.8M | 0.03% |
401,568
-5,733
| -1% | -$167K |
|
554
Vistra
VST
$47.1B
| $10.8M | 0.03% |
572,124
+10,908
| +2% | +$206K |
|
555
Avantor
AVTR
$10.6B
| $10.7M | 0.03% |
477,330
+389,385
| +443% | +$8.1M |
|
556
Pacira BioSciences
PCRX
$993M
| $10.7M | 0.03% |
178,405
+74,396
| +72% | +$4.32M |
|
|
CASI
557
DELISTED
CASI Pharmaceuticals
CASI
| $10.6M | 0.02% |
+690,000
| New | +$13M |
|
558
Workhorse Group
WKHS
$33.1M
| $10.5M | 0.02% |
+139
| New | +$7.95M |
|
559
Cigna
CI
$74.1B
| $10.5M | 0.02% |
61,878
-4,866
| -7% | -$856K |
|
560
Acuity Brands
AYI
$8.89B
| $10.4M | 0.02% |
101,896
-6,498
| -6% | -$668K |
|
561
Choice Hotels
CHH
$4.42B
| $10.4M | 0.02% |
120,969
-1,304
| -1% | -$117K |
|
562
Camping World
CWH
$355M
| $10.4M | 0.02% |
348,314
+27,516
| +9% | +$898K |
|
563
ICICI Bank
IBN
$101B
| $10.3M | 0.02% |
1,049,672
-117,761
| -10% | -$1.17M |
|
|
GLUU
564
DELISTED
Glu Mobile Inc.
GLUU
| $10.3M | 0.02% |
1,340,500
+405,000
| +43% | +$3.4M |
|
|
ORTX
565
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $10.3M | 0.02% |
250,000
-18,150
| -7% | -$938K |
|
566
CVS Health
CVS
$117B
| $10.2M | 0.02% |
175,331
+5,756
| +3% | +$358K |
|
567
Fomento Económico Mexicano
FMX
$41.2B
| $10.2M | 0.02% |
181,124
+24,575
| +16% | +$1.43M |
|
568
Alaska Air
ALK
$4.43B
| $10.1M | 0.02% |
277,035
-6,139
| -2% | -$230K |
|
|
CLR
569
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $10.1M | 0.02% |
820,355
-131,415
| -14% | -$2.13M |
|
570
SI-BONE Inc
SIBN
$831M
| $10M | 0.02% |
421,737
+51,737
| +14% | +$1.03M |
|
|
TCDA
571
DELISTED
Tricida, Inc. Common Stock
TCDA
| $9.91M | 0.02% |
1,094,193
+716,039
| +189% | +$10.5M |
|
572
Fortis
FTS
$27.5B
| $9.91M | 0.02% |
242,467
-7,313
| -3% | -$292K |
|
573
Revolve Group
RVLV
$1.47B
| $9.86M | 0.02% |
600,000
+80,000
| +15% | +$1.44M |
|
574
Transmedics
TMDX
$3.04B
| $9.83M | 0.02% |
713,220
-819,242
| -53% | -$14M |
|
575
Myriad Genetics
MYGN
$369M
| $9.81M | 0.02% |
751,983
-609,441
| -45% | -$7.71M |
|
Similar funds
Federated Hermes's Q3 2020 Portfolio in Review
As of Q3 2020, Federated Hermes held 2,428 positions worth $42.6B, up 5.5% from $40.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q3 2020 filing shows 206 new, 703 increased, 1,198 reduced and 187 closed positions. Its largest new stake was Snowflake: 234,132 shares worth $58.8M. The largest sale was Alibaba, an estimated $370M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q3 2020 buy was Snowflake: 234,132 shares worth $58.8M.
- Federated Hermes added most to Gilead Sciences in Q3 2020, an estimated $204M increase.
- Federated Hermes's biggest Q3 2020 reduction was Alibaba, cutting an estimated $370M.
- Federated Hermes fully exited BP in Q3 2020, selling an estimated $65.1M.
- Federated Hermes's ten largest holdings make up 15% of its $42.6B portfolio in Q3 2020.
- Federated Hermes opened 206 new positions and closed 187 in Q3 2020.
- Federated Hermes's portfolio value rose 5.5% quarter-over-quarter to $42.6B.
Based on Federated Hermes's 13F filing for Q3 2020, filed 12 Nov 2020.